Response to Letter Regarding Article, “Fibroblast Growth Factor 23 and Risk of Incident Stroke in CommunityLiving Adults” We thank Drs Zou and Zheng for their comments. We agree that future research will need to establish whether measuring fibroblast growth factor 23 may be useful for reducing stroke rates, either as a biomarker for improving cardioembolic stroke risk stratification or potentia...

The death rate among chronic kidney disease patients is the highest compared to other chronic diseases. 60% of these fatalities are cardiovascular. Cardiovascular calcifications and chronic inflammation affect almost all chronic kidney disease patients and are associated with cardiovascular mortality. Fibroblast growth factor 23 is associated with vascular calcification. Systemic inflammation i...